Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

UP Therapeutics Inc
Profile last edited on: 7/6/2022      CAGE: 7QR53      UEI: KVFLK2JVJST8

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2016
First Award
2021
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

4539 Metropolitan Court Lab 260I
Frederick, MD 21704
   (443) 827-2083
   rkanchoori@uptherapeutics.com
   www.uptherapeutics.com
Location: Single
Congr. District: 06
County: Frederick

Public Profile

A preclinical stage biotech company, Up Therapeutics is structured around the task of improving the quality and the span of the cancer patientÂ’s life by leveraging the firm's proprietary novel class of small molecule Rpn13 inhibitors.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$653,516
Phase II Dollars
$55,000
Total Awarded
$708,516

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2022 1 NIH $308,516
Project Title: Developing a RPN13 inhibitor for the treatment of Quadruple Negative Breast Cancer
2022 1 NIH $400,000
Project Title: Development of small molecule RPN13 inhibitors for Treatment of Glioblastoma
0 1 NIH $868,417
Project Title: Development of a novel small molecule RPN13 inhibitor and therapeutic for advanced ovarian cancer patients

Key People / Management

  Ravi Kumar Anchoori -- Founder and CSO

  Yuexia Li -- COO. Regulatory Affairs advisor

  Raymond Soomg -- CMO

Company News

There are no news available.